We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Microorganisms Identified by Microbial Detection Array in 24 Hours

By LabMedica International staff writers
Posted on 12 May 2010
A microbial detection array provides scientists with the capability of identifying pathogens over the entire range of known viruses and bacteria.

The array detects microorganisms with the use of 388,000 probes that fit in a checkerboard pattern in the middle of a 2.54-cm wide, 7.62-cm long glass slide. More...
It will be useful for medical professionals diagnosing diseases, regulatory agencies checking product safety, and law enforcement authorities seeking to detect bioterrorism attacks.

The current operational version of the Lawrence Livermore National Laboratory (LLMD; Livermore, CA, USA) detection array (LLMDA) contains probes that can detect more than 2,000 viruses and about 900 bacteria. Scientists will be able to detect all known bacterial and viral pathogens in comparison to current multiplex polymerase chain reaction (PCR) techniques that can at best offer detection from among 50 organisms in one test.

In an online article on April 7, 2010, in the Journal of Virology, Livermore investigators working with a scientist from the Blood Systems Research Institute (San Francisco, CA, USA) said that they used the LLMDA technology to confirm the presence of an apparently benign pig virus in a vaccine. The pig virus, porcine circovirus-1 (PCV-1), was unexpectedly found in GlaxoSmithKline's (Brentford, UK) Rotarix vaccine, which is used to prevent diarrhea in babies.

"The ability to detect the major bacterial and viral components of any sample can be used in countless different ways," said Tom Slezak, LLNL's associate program leader for Informatics. "This is important because it fills a cost-performance gap that is relevant to many missions: biodefense, public health, and product safety."

Related Links:

Lawrence Livermore National Laboratory
Blood Systems Research Institute
GlaxoSmithKline




New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.